MRI Features and Pathology Grade in Ductal Carcinoma in Situ
1.Department of Radiology,Taizhou Municipal Hospital,Taizhou 318000,China
2.Department of Radiology,Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China
3.Department of Pathology,Taizhou Municipal Hospital,Taizhou 318000,China
* Corresponding author:WANG Dengbin,Professor,Chief physician;E-mail:dbwang8@yahoo.com.cn
[1]RECHT A,RUTGERS E J,FENTIMAN I S,et al.The fourth EORTC DCIS consensus meeting (chateau marquette,heemskerk,the Netherlands,23-24 January 1998)——conference report[J].Eur J Cancer,1998,34(11):1664-1669.
[2]MOKBEL K,CUTULI B.Heterogeneity of ductal carcinoma in situ and its effects on management[J].Lancet Oncol,2006,7(9):756-765.DOI:10.1016/S1470-2045(06)70861-0.
[3](美)美国放射学院,著.乳腺影像报告与数据系统图谱(2013版)[M].王殊,译.北京:北京大学医学出版社,2016:303-372.
[4]刘万花.乳腺比较影像诊断学[M].南京:东南大学出版社,2017:131-143.
[5]SILVERSTEIN M J,LAGIOS M D,CRAIG P H,et al.A prognostic index for ductal carcinoma in situ of the breast [J].Cancer,1996,77(11):2267-2274.
[6]MORAKKABATI-SPITZ N,LEUTNER C,SCHILD H,et al.Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI[J].Eur Radiol,2005,15(9):2010-2017.DOI:10.1007/s00330-005-2755-4.
[7]TOZAKI M,IGARASHI T,FUKUDA K.Breast MRI using the VIBE sequence:clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement[J].AJR Am J Roentgenol,2006,187(2):313-321.DOI:10.2214/AJR.05.0881.
[8]TOZAKI M,FUKUDA K.High-spatial-resolution MRI of non-masslike breast lesions:interpretation model based on BI-RADS MRI descriptors[J].AJR Am J Roentgenol,2006,187(2):330-337.DOI:10.2214/ajr.187.3.w330.
[9]FURMAN-HARAN E,SCHECHTMAN E,KELCZ F,et al.Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions[J].Cancer,2005,104(4):708-718.DOI:10.1002/cncr.21225.
[10]LIBERMAN L,MORRIS E A,LEE M J,et al.Breast lesions detected on MR imaging:features and positive predictive value[J].AJR Am J Roentgenol,2002,179(1):171-178.DOI:10.2214/ajr.179.1.1790171.
[11]姜婷婷,顾雅佳,彭卫军,等.乳腺导管原位癌的MRI表现及与病理分级的关系[J].中国癌症杂志,2013,23(8):631-636.DOI:10.3969/j.issn.1007-3969.2013.08.012.
JIANG T T,GU Y J,PENG W J,et al.The MRI of ductal carcinoma in situ with pathology grade[J].China Oncology,2013,23(8):631-636.DOI:10.3969/j.issn.1007-3969.2013.08.012.
[12]徐茂林,苏丹柯,谢东,等.非肿块型强化的乳腺磁共振成像表现扩散系数值与HER-2表达的相关性分析[J].磁共振成像,2015,6(7):513-517.DOI:10.3969/j.issn.1674-8034.2015.07.007.
XU M L,SU D K,XIE D,et al Correlation of MR apparent diffusion coefifcient value with HER-2 expression in non-mass-like breast carcinoma [J].Chin J Magn Reson Imaging,2015,6(7):513-517.DOI:10.3969/j.issn.1674-8034.2015.07.007.
[13]LEHOTSKA V,RAUOVA K,VANOVCANOVA L.Multiparametric MRI analysis of morphologico-functional features of DCIS-correlation with grade of nuclear atypia[J].Neoplasma,2018,65(3):389-397.DOI:10.4149/neo_2018_170509N333.
[14]许玲辉,彭卫军,顾雅佳,等.乳腺导管原位癌的MRI表现[J].中华放射学杂志,2011,45(2):159-163.DOI:10.3760/cma.j.issn.1005-1201.2011.02.015.
XU L H,PENG W J,GU Y J,et al.MRI characteristics of ductal carcinoma in situ of the breast[J].Chinese Journal of Radiology,2011,45(2):159-163.DOI:10.3760/cma.j.issn.1005-1201.2011.02.015.
[15]丁华野.乳腺病理诊断和鉴别诊断[M].北京:人民卫生出版社,2017:111-115.
[16]LEE S M,NAM K J,CHOO K S,et al.Patterns of malignant non-mass enhancement on 3-T breast MRI help predict invasiveness:using the BI-RADS lexicon fifth edition[J].Acta Radiol,2018,59(11):1292-1299.DOI:10.1177/0284185118759139.
[17]边甜甜,林青,吴增杰,等.乳腺化生性癌的影像学与临床病理特征[J].中华肿瘤杂志,2016,38(10):767-768.DOI:10.3760/cma.j.issn.0253-3766.2016.10.011.
BIAN T T,LIN Q,WU Z J,et al.Metaplastic carcinoma of the breast:imaging features and clinicopathological characteristics[J].Chinese Journal of Oncology,2016,38(10):767-768.DOI:10.3760/cma.j.issn.0253-3766.2016.10.011.